“Megatherapy” for advanced neuroblastoma—Rationale and role
- 31 December 1995
- journal article
- editorial
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (2) , 134-136
- https://doi.org/10.1016/0959-8049(95)00035-h
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- High‐dose consolidation with local radiation and bone marrow rescue in patients with advanced neuroblastomaMedical and Pediatric Oncology, 1994
- Treatment of advanced neuroblastomaEuropean Journal Of Cancer, 1993
- Pilot study of high-dose vincristine, etoposide, carboplatin and melphalan with autologous bone marrow rescue in advanced neuroblastomaEuropean Journal Of Cancer, 1992
- Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Children's Cancer Study Group investigation.Journal of Clinical Oncology, 1992
- Treatment of advanced neuroblastoma with i-131 meta-iodobenzylguanidineCancer, 1991
- High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: an unselected group of stage IV patients over 1 year of age.Journal of Clinical Oncology, 1987
- Treatment of advanced neuroblastoma with high-dose melphalan and autologous bone marrow transplantationCancer Chemotherapy and Pharmacology, 1986
- The radiobiology of human neuroblastomaRadiotherapy and Oncology, 1985
- Immunolocalization of neuroblastoma using radiolabeled monoclonal antibody UJ13AThe Journal of Pediatrics, 1984
- High-dose melphalan with autologous marrow for treatment of advanced neuroblastomaBritish Journal of Cancer, 1982